The present application describes methods for treating cancer with anti-ErbB2 antibodies, such as humanized anti-ErbB2 antibodies, and anti-hormonal compounds, such as anti-estrogens.

 
Web www.patentalert.com

< Systems and methods for treating patients with processed lipoaspirate cells

> Method for universal enzymatic production of bioactive peptides

> Antiangiogenic agents
~ 00505